Pridinol
Clinical data
Myopridin
By mouth, parenteral
Legal status
Identifiers
1,1-Diphenyl-3-(piperidin-1-yl)propan-1-ol
NPubChem CID
N
YCompTox Dashboard (EPA)
Chemical and physical data
C20H25NO
295.426 g·mol−1
InChI=1S/C20H25NO/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1-2,4-7,10-13,22H,3,8-9,14-17H2 Y
Key:RQXCLMGKHJWMOA-UHFFFAOYSA-N Y
Pridinol, sold under the brand name Myopridin, is a muscle relaxant that is used as an antiparkinsonian and anticholinergic drug.[1]
It was approved for medical use in the UK in May 2020.[2]
Peripherally acting
(primarily antinicotinic,
NMJ block)
Other
mAChRsTooltip Muscarinic acetylcholine receptors
Precursors
(and prodrugs)
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.
